Lijin Lin Selected Research

Lijin Lin Research Topics

5	COVID-19 01/2022 - 01/2020
2	Chronic Renal Insufficiency 08/2023 - 01/2023
2	Hypertension (High Blood Pressure) 01/2023 - 01/2020
2	Stroke (Strokes) 08/2022 - 01/2020
2	Inflammation (Inflammations) 10/2020 - 01/2020
1	Iron Deficiencies 11/2023
1	Obesity 11/2023
1	Tetraploidy 02/2023
1	Potassium Deficiency 01/2023
1	Hyperuricemia 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Disease Progression 01/2022
1	Hyperglycemia 01/2021
1	Acidosis 10/2020
1	Heart Failure 10/2020
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Heart Diseases (Heart Disease) 10/2020

3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 08/2022
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 10/2020
2	HDL CholesterolIBA 11/2023 - 01/2022
2	LipidsIBA 01/2023 - 01/2020
1	MelatoninIBA 11/2023
1	IronIBA 11/2023
1	Triglycerides (Triacylglycerol)IBA 11/2023
1	Particulate MatterIBA 08/2023
1	Colchicine FDA LinkGeneric 02/2023
1	SugarsIBA 01/2023
1	Anthocyanins (Anthocyanin)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Apolipoproteins B (ApoB)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2022
1	ProcalcitoninIBA 01/2022
1	BilirubinIBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	NitrogenIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020

1	Therapeutics 01/2020
1	Intravenous Administration 01/2020